These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 June. The technology gains life-saving medical insights by analysing human excrement. Şirket, tıbbi tuvalet sensörünün unsurlarını kapsayan bir dizi üç patent başvurusunda bulundu..

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Avrupa, Japonya ve Çin.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, OutSense teknolojisi gastrointestinal sistem boyunca kanın kaynağını tanımlayabiliyor.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

OutSense CEO'su Yfat Scialom'a göre, who predicts that “dijital tıbbın patlamasıyla, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, inflamatuar bağırsak hastalığı ve idrar yolu enfeksiyonları.

Its solution consists of a multispectral optical sensor, bir ışık kaynağı ve WiFi bağlantısı içeren otonom bir tarama cihazı. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Örneklenen kandan elde edilen bilgiler, kanamadan atılımına kadar geçen sürenin ek analizi ile birlikte, kanama patolojisinin ayrıntılarını sağlar. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense CommuniCare'i duyurdu, fazlasına sahip büyük bir sağlık şirketi 90 healthcare facilities in the US, Bu yıl teknolojisinin pilot uygulamalarına başlayacak. Bu pilotun yanı sıra, OutSense also plans to conduct clinical trials in Israel and Japan.